Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BFLY Butterfly Network	$2.00 +1.3%	$2.31	$0.82 ▼ $4.98	$487.16M	2.54	3.12 million shs	3.79 million shs
BVS Bioventus	$6.66 -0.4%	$6.81	$5.47 ▼ $14.38	$547.08M	0.86	449,093 shs	358,334 shs
KIDS OrthoPediatrics	$21.77 +0.8%	$21.38	$19.52 ▼ $35.99	$524.35M	1.08	200,236 shs	97,621 shs
RCEL Avita Medical	$5.12 +7.3%	$7.04	$4.71 ▼ $14.16	$126.09M	1.55	183,689 shs	370,473 shs

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BFLY Butterfly Network	+1.27%	-7.85%	-21.76%	-15.61%	+112.23%
BVS Bioventus	-0.45%	+3.58%	+1.99%	-26.25%	+18.93%
KIDS OrthoPediatrics	+0.83%	+8.04%	+3.08%	-12.00%	-21.55%
RCEL Avita Medical	+7.34%	-2.48%	-15.65%	-41.35%	-35.60%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BFLY Butterfly Network	1.7716 of 5 stars	3.5	1.0	0.0	0.6	2.5	0.6
BVS Bioventus	2.6024 of 5 stars	3.3	0.0	0.0	0.0	4.2	1.3
KIDS OrthoPediatrics	4.3353 of 5 stars	3.4	2.0	3.9	3.2	3.3	0.6
RCEL Avita Medical	1.2463 of 5 stars	3.4	0.0	0.0	2.2	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BFLY Butterfly Network	3.00	Buy	$4.00	100.50% Upside
BVS Bioventus	2.67	Moderate Buy	$14.33	115.22% Upside
KIDS OrthoPediatrics	2.83	Moderate Buy	$35.83	64.60% Upside
RCEL Avita Medical	2.75	Moderate Buy	$16.50	222.27% Upside

Current Analyst Ratings Breakdown

Latest RCEL, BVS, BFLY, and KIDS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/6/2025	RCEL Avita Medical	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$19.00
5/8/2025	KIDS OrthoPediatrics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$40.00 ➝ $30.00
5/8/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
5/7/2025	BVS Bioventus	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$15.00
5/5/2025	BFLY Butterfly Network	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$5.00 ➝ $4.00
4/11/2025	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$26.00 ➝ $24.00
4/10/2025	RCEL Avita Medical	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$22.00 ➝ $22.00
4/9/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
4/7/2025	KIDS OrthoPediatrics	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$37.00
4/4/2025	RCEL Avita Medical	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$22.00 ➝ $22.00

(Data available from 6/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BFLY Butterfly Network	$82.06M	6.01	N/A	N/A	$0.79 per share	2.53
BVS Bioventus	$567.70M	0.96	$0.53 per share	12.58	$2.80 per share	2.38
KIDS OrthoPediatrics	$204.73M	2.58	N/A	N/A	$14.64 per share	1.49
RCEL Avita Medical	$64.25M	2.11	N/A	N/A	$0.17 per share	30.12

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BFLY Butterfly Network	-$72.49M	-$0.29	N/A	N/A	N/A	-75.56%	-29.97%	-21.13%	8/7/2025 (Estimated)
BVS Bioventus	-$156.23M	-$0.48	N/A	14.48	N/A	-7.11%	15.61%	4.01%	N/A
KIDS OrthoPediatrics	-$37.82M	-$1.75	N/A	N/A	N/A	-19.15%	-7.03%	-5.45%	8/4/2025 (Estimated)
RCEL Avita Medical	-$61.85M	-$2.19	N/A	N/A	N/A	-79.61%	-632.62%	-71.72%	8/6/2025 (Estimated)

Latest RCEL, BVS, BFLY, and KIDS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/8/2025	Q1 2025	RCEL Avita Medical	-$0.39	-$0.53	-$0.14	-$0.53	$33.15 million	$18.51 million
5/7/2025	Q1 2025	KIDS OrthoPediatrics	-$0.26	-$0.39	-$0.13	-$0.46	$51.68 million	$52.41 million
5/2/2025	Q1 2025	BFLY Butterfly Network	-$0.09	-$0.06	+$0.03	-$0.06	$21.16 million	$21.23 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BFLY Butterfly Network	N/A	N/A	N/A	N/A	N/A
BVS Bioventus	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
RCEL Avita Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BFLY Butterfly Network	N/A	6.06	4.43
BVS Bioventus	1.85	1.41	0.99
KIDS OrthoPediatrics	0.21	6.19	2.99
RCEL Avita Medical	9.39	2.09	1.72

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BFLY Butterfly Network	37.85%
BVS Bioventus	62.94%
KIDS OrthoPediatrics	69.05%
RCEL Avita Medical	27.66%

Insider Ownership

Company	Insider Ownership
BFLY Butterfly Network	25.18%
BVS Bioventus	33.00%
KIDS OrthoPediatrics	32.70%
RCEL Avita Medical	2.80%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BFLY Butterfly Network	460	247.29 million	185.02 million	Optionable
BVS Bioventus	1,200	82.14 million	54.46 million	Not Optionable
KIDS OrthoPediatrics	200	24.29 million	16.35 million	Optionable
RCEL Avita Medical	130	26.43 million	25.70 million	Optionable

RCEL, BVS, BFLY, and KIDS Headlines

Recent News About These Companies

Analysts Expect Breakeven For AVITA Medical, Inc. (NASDAQ:RCEL) Before Long

June 21, 2025 | finance.yahoo.com

Cantor Fitzgerald Predicts AVITA Medical FY2026 Earnings

June 11, 2025 | marketbeat.com

AVITA Medical (NASDAQ:RCEL) Given Buy Rating at D. Boral Capital

June 6, 2025 | marketbeat.com

AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™

June 5, 2025 | finance.yahoo.com

AVITA Medical's RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards

June 3, 2025 | globenewswire.com

Short Interest in AVITA Medical, Inc. (NASDAQ:RCEL) Rises By 23.9%

June 3, 2025 | marketbeat.com

AVITA Medical’s Acute Wound Care Showcase 2025 Streams Live Today

May 13, 2025 | finance.yahoo.com

AVITA Medical: Near-Perfect Execution Needed To Navigate Through Balance Sheet Challenges

May 12, 2025 | seekingalpha.com

Analysts Have Been Trimming Their AVITA Medical, Inc. (NASDAQ:RCEL) Price Target After Its Latest Report

May 11, 2025 | finance.yahoo.com

AVITA Medical, Inc. (RCEL) Q1 2025 Earnings Call Transcript

May 8, 2025 | seekingalpha.com

AVITA Medical Reports First Quarter 2025 Financial Results

May 8, 2025 | globenewswire.com

AVITA Medical to Announce First Quarter 2025 Financial Results

April 17, 2025 | globenewswire.com

AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025

April 9, 2025 | globenewswire.com

6 Analysts Assess AVITA Medical: What You Need To Know

April 6, 2025 | nasdaq.com

Avita Medical announces U.S. commercial launch of Cohealyx

April 4, 2025 | msn.com

AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity

April 3, 2025 | globenewswire.com

AVITA Medical’s SWOT analysis: regenerative medicine stock faces growth hurdles

March 21, 2025 | uk.investing.com

4RCEL : What Analysts Are Saying About AVITA Medical Stock

March 18, 2025 | benzinga.com

Avita Medical amends PermeaDerm distribution agreement with Stedical Scientific

March 17, 2025 | markets.businessinsider.com

Avita Medical Boosts Production with New Agreement

March 17, 2025 | tipranks.com

AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific

March 17, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
3 Defense Stocks That Will Profit From a Golden Dome
By Chris Markoch | May 30, 2025
View 3 Defense Stocks That Will Profit From a Golden Dome
BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
By Gabriel Osorio-Mazilli | June 23, 2025
View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
Intel's Turnaround Strategy Shifts From Planning to Attack Mode
By Jeffrey Neal Johnson | June 20, 2025
View Intel's Turnaround Strategy Shifts From Planning to Attack Mode
UPS Is Outpacing the Market: A Green Light for Investors?
By Jeffrey Neal Johnson | June 27, 2025
View UPS Is Outpacing the Market: A Green Light for Investors?

RCEL, BVS, BFLY, and KIDS Company Descriptions

Butterfly Network NYSE:BFLY

$2.00 +0.03 (+1.27%)

Closing price 06/26/2025 03:59 PM Eastern

Extended Trading

$2.04 +0.04 (+2.26%)

As of 08:29 AM Eastern

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

Bioventus NYSE:BVS

$6.66 -0.03 (-0.45%)

Closing price 06/26/2025 04:00 PM Eastern

Extended Trading

$6.59 -0.07 (-1.04%)

As of 07:27 AM Eastern

Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina.

OrthoPediatrics NASDAQ:KIDS

$21.77 +0.18 (+0.83%)

Closing price 06/26/2025 04:00 PM Eastern

Extended Trading

$21.77 0.00 (0.00%)

As of 06/26/2025 05:11 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Avita Medical NASDAQ:RCEL

$5.12 +0.35 (+7.34%)

Closing price 06/26/2025 04:00 PM Eastern

Extended Trading

$5.30 +0.19 (+3.61%)

As of 08:21 AM Eastern

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time